AKT1 and hepatocellular carcinoma: The PI3K/AKT/mTOR pathway is altered in HCC due to dysregulation of receptor tyrosine kinases (RTKs), which activate the lipid kinase PI3K, catalyzing phosphorylation of phosphatidylinositol [74].